Owen C - Search Results

1

Preferences of patients and physicians concerning treatment options for relapsed follicular lymphoma: a discrete choice experiment.

Shafey M, Lupichuk SM, Do T, Owen C, Stewart DA. Shafey M, et al. Among authors: owen c. Bone Marrow Transplant. 2011 Jul;46(7):962-9. doi: 10.1038/bmt.2010.225. Epub 2010 Oct 11. Bone Marrow Transplant. 2011. PMID: 20935681

2

Durable event-free survival following autologous stem cell transplant for relapsed or refractory follicular lymphoma: positive impact of recent rituximab exposure and low-risk Follicular Lymphoma International Prognostic Index score.

Peters AC, Duan Q, Russell JA, Duggan P, Owen C, Stewart DA. Peters AC, et al. Among authors: owen c. Leuk Lymphoma. 2011 Nov;52(11):2124-9. doi: 10.3109/10428194.2011.594925. Epub 2011 Jul 8. Leuk Lymphoma. 2011. PMID: 21740097

3

Upfront thiotepa, busulfan, cyclophosphamide, and autologous stem cell transplantation for primary CNS lymphoma: a single centre experience.

Alimohamed N, Daly A, Owen C, Duggan P, Stewart DA. Alimohamed N, et al. Among authors: owen c. Leuk Lymphoma. 2012 May;53(5):862-7. doi: 10.3109/10428194.2011.633250. Epub 2011 Dec 6. Leuk Lymphoma. 2012. PMID: 22023529 Clinical Trial.

4

Obinutuzumab for the treatment of lymphoproliferative disorders.

Owen C, Stewart DA. Owen C, et al. Expert Opin Biol Ther. 2012 Mar;12(3):343-51. doi: 10.1517/14712598.2012.657622. Epub 2012 Jan 28. Expert Opin Biol Ther. 2012. PMID: 22283718 Review.

5

Results of a prospective phase II trial evaluating interim positron emission tomography-guided high dose therapy for poor prognosis diffuse large B-cell lymphoma.

Stewart DA, Kloiber R, Owen C, Bahlis NJ, Duggan P, Mansoor A, Bence-Bruckler I. Stewart DA, et al. Among authors: owen c. Leuk Lymphoma. 2014 Sep;55(9):2064-70. doi: 10.3109/10428194.2013.862242. Epub 2014 Feb 17. Leuk Lymphoma. 2014. PMID: 24188476 Clinical Trial.

6

Obinutuzumab for B-cell malignancies.

Owen CJ, Stewart DA. Owen CJ, et al. Expert Opin Biol Ther. 2014 Aug;14(8):1197-205. doi: 10.1517/14712598.2014.922535. Epub 2014 May 23. Expert Opin Biol Ther. 2014. PMID: 24856933 Review.

7

Comparative effectiveness analysis of different salvage therapy intensities used for diffuse large B-cell lymphoma in Northern or Southern Alberta: an instrumental variable analysis.

Oh DH, Ghosh S, Chua N, Kostaras X, Tilley D, Chu M, Owen CJ, Stewart DA. Oh DH, et al. Leuk Lymphoma. 2015 Jun;56(6):1756-62. doi: 10.3109/10428194.2014.971409. Epub 2014 Nov 3. Leuk Lymphoma. 2015. PMID: 25284495

8

Obinutuzumab for the treatment of patients with previously untreated chronic lymphocytic leukemia: overview and perspective.

Owen CJ, Stewart DA. Owen CJ, et al. Ther Adv Hematol. 2015 Aug;6(4):161-70. doi: 10.1177/2040620715586528. Ther Adv Hematol. 2015. PMID: 26288711 Free PMC article. Review.

9

Quantifying Benefit of Autologous Transplantation for Relapsed Follicular Lymphoma Patients via Instrumental Variable Analysis.

Oh DH, Li H, Duan Q, Villa D, Peters A, Chua N, Owen CJ, Connors JM, Stewart DA. Oh DH, et al. Biol Blood Marrow Transplant. 2016 May;22(5):941-8. doi: 10.1016/j.bbmt.2016.01.015. Epub 2016 Jan 16. Biol Blood Marrow Transplant. 2016. PMID: 26785331 Free article. Clinical Trial.

10

Obinutuzumab for the First-Line Treatment of Follicular Lymphoma.

Marcus R, Davies A, Ando K, Klapper W, Opat S, Owen C, Phillips E, Sangha R, Schlag R, Seymour JF, Townsend W, Trněný M, Wenger M, Fingerle-Rowson G, Rufibach K, Moore T, Herold M, Hiddemann W. Marcus R, et al. Among authors: owen c. N Engl J Med. 2017 Oct 5;377(14):1331-1344. doi: 10.1056/NEJMoa1614598. N Engl J Med. 2017. PMID: 28976863 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,700 results

Search Page

Filters